1. HIGHLIGHTS OF PRESCRIBING INFORMATION . These highlights do not include all the information needed to use LAMICTAL safely and effectively. See full prescribing information for
1. HIGHLIGHTS OF PRESCRIBING INFORMATION . These highlights do not include all the information needed to use LAMICTAL XR safely and effectively. See full prescribing information
NDA 020241/S-049 NDA 020764/ S-042 NDA 022251/S-012 FDA Approved Labeling Text dated 11/29/2011 Page 56 . MEDICATION GUIDE . LAMICTAL ® (la-MIK-tal)
Lamictal (lamotrigine) Generic name: Lamotrigine Available strengths: 25 mg, 100 mg, 150 mg, 200 mg tablets Available in generic: No Drug class: Anticonvulsant/mood stabilizer General Information Lamictal (lamotrigine) is better known as an anticonvulsant—a medication for treating epilepsy.
LAMICTAL ® (dispersible/chewable) Tablets Lamotrigine Consumer Medicine Information What is in this leaflet? Please read this leaflet carefully before you take Lamictal tablets.
[17-JAN-2003] LAMICTAL ® PRODUCT INFORMATION 1 (lamotrigine) 2 Tablets 3 4 LAMICTAL ® 5 (lamotrigine) 6 Chewable Dispersible Tablets 7 8 9 SERIOUS RASHES REQUIRING HOSPITALIZATION AND DISCONTINUATION 10 OF TREATMENT HAVE BEEN REPORTED IN ASSOCIATION WITH THE USE 11 OF LAMICTAL.
1 PRESCRIBING INFORMATION 1 LAMICTAL ® 2 (lamotrigine) 3 Tablets 4 5 LAMICTAL ® 6 (lamotrigine) 7 Chewable Dispersible Tablets 8 9 SERIOUS RASHES REQUIRING HOSPITALIZATION AND DISCONTINUATION 10 OF TREATMENT HAVE BEEN REPORTED IN ASSOCIATION WITH THE USE OF 11 LAMICTAL.
NDA 022115/S-016 FDA Approved Labeling Text dated 11/29/2011 Page 41 . 1266 clearly. Depictions of the LAMICTAL XR Extended-Release Tablets can be found in the
Page 1 of 7 Lamictal® (lamotrigine) Important Warning : Serious skin rashes requiring medical hospitalization and discontinuation of treatment have been associated with Lamictal.
Client Initial Date DEPARTMENT OF HEALTH SERVICES Division of Mental Health and Substance Abuse Services F-24277 (12/2010) STATE OF WISCONSIN 42 CFR483.420(a) (2) DHS 134.31(3)(o) DHS 94.03 & 94.09 s.51.61(1)(g) & (h ) INFORMED CONSENT FOR MEDICATION Dosage and / or Side Effect information last ...